Terms: = Colorectal cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
41 results:
1. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
[TBL] [Abstract] [Full Text] [Related]
2. Implementation of an organized colorectal cancer screening program through quantitative fecal immunochemical test followed by colonoscopy in an urban low-income community: Guidance and strategies.
Ribeiro U; Safatle-Ribeiro AV; Sorbello M; Kishi PHR; Cohend DD; Mattar R; Castilho VLP; Goncalves EMDN; Kawaguti F; Marques CFS; Alves VAF; Nahas SC; Eluf-Neto J
Clinics (Sao Paulo); 2023; 78():100278. PubMed ID: 37639912
[TBL] [Abstract] [Full Text] [Related]
3. Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis.
Khanmohammadi S; Behnoush AH; Akhlaghpoor S
PLoS One; 2023; 18(8):e0289975. PubMed ID: 37585405
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
[TBL] [Abstract] [Full Text] [Related]
5. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with colorectal Liver Metastases.
Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
[TBL] [Abstract] [Full Text] [Related]
6. Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
Franzese C; Vernier V; Franceschini D; Comito T; Navarria P; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Marini B; Galdieri C; Mancosu P; Tomatis S; Scorsetti M
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10495-10503. PubMed ID: 37280407
[TBL] [Abstract] [Full Text] [Related]
7. Surgical outcomes of left hemicolon sparing resection versus extensive resection in treating synchronous colorectal cancer involving the right-sided colon and sigmoid colon or rectum.
Quan J; Liu J; Zhou S; Mei S; Qiu W; Wan Y; Wang X; Tang J
World J Surg Oncol; 2023 Apr; 21(1):131. PubMed ID: 37055785
[TBL] [Abstract] [Full Text] [Related]
8. Dysbiosis of the stool DNA and RNA virome in Crohn's disease.
Kong C; Liu G; Kalady MF; Jin T; Ma Y
J Med Virol; 2023 Feb; 95(2):e28573. PubMed ID: 36772850
[TBL] [Abstract] [Full Text] [Related]
9. Anastomotic perfusion assessment with indocyanine green in robot-assisted low-anterior resection, a multicenter study of interobserver variation.
Larsen PO; Nerup N; Andersen J; Dohrn N; Klein MF; Brisling S; Salomon S; Andersen PV; Möller S; Svendsen MBS; Rahr HB; Iversen LH; Gögenur I; Qvist N; Ellebaek MB
Surg Endosc; 2023 May; 37(5):3602-3609. PubMed ID: 36624218
[TBL] [Abstract] [Full Text] [Related]
10.
van 't Erve I; Wesdorp NJ; Medina JE; Ferreira L; Leal A; Huiskens J; Bolhuis K; van Waesberghe JTM; Swijnenburg RJ; van den Broek D; Velculescu VE; Kazemier G; Punt CJA; Meijer GA; Fijneman RJA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820593
[TBL] [Abstract] [Full Text] [Related]
11. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
Ghani MA; Fereydooni A; Chen E; Letzen B; Laage-Gaupp F; Nezami N; Deng Y; Gan G; Thakur V; Lin M; Papademetris X; Schernthaner RE; Huber S; Chapiro J; Hong K; Georgiades C
Eur Radiol; 2021 Dec; 31(12):8858-8867. PubMed ID: 34061209
[TBL] [Abstract] [Full Text] [Related]
12. Can we optimize CEA as a response marker in rectal cancer?
Gago T; Caldeira P; Cunha AC; Campelo P; Guerreiro H
Rev Esp Enferm Dig; 2021 Jun; 113(6):423-428. PubMed ID: 33228364
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.
Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A
Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922
[TBL] [Abstract] [Full Text] [Related]
14. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
[TBL] [Abstract] [Full Text] [Related]
15. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract] [Full Text] [Related]
16. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract] [Full Text] [Related]
17. Contribution of extended family history in assessment of risk for breast and colon cancer.
Solomon BL; Whitman T; Wood ME
BMC Fam Pract; 2016 Sep; 17(1):126. PubMed ID: 27580697
[TBL] [Abstract] [Full Text] [Related]
18. Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis.
Giglio MC; Giakoustidis A; Draz A; Jawad ZAR; Pai M; Habib NA; Tait P; Frampton AE; Jiao LR
Ann Surg Oncol; 2016 Oct; 23(11):3709-3717. PubMed ID: 27272106
[TBL] [Abstract] [Full Text] [Related]
19. Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines.
Tsunekawa N; Higashi N; Kogane Y; Waki M; Shida H; Nishimura Y; Adachi H; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2016 Jan; 469(4):878-83. PubMed ID: 26713365
[TBL] [Abstract] [Full Text] [Related]
20. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
[TBL] [Abstract] [Full Text] [Related]
[Next]
